/

Other

/

Merz Therapeutics

Merz Therapeutics

Merz Therapeutics

Verified Nov 2026

Other

·

Germany flag

Frankfurt, Hesse

·

Since 2020

Merz Therapeutics is a specialty pharmaceutical company headquartered in Frankfurt, Germany, founded in 2020, with 1,000–5,000 employees and estimated revenue of $250–500 million. Part of the Merz Group, which traces its heritage to 1908, the company develops treatments for neurological movement disorders, neurodegenerative diseases, and related conditions. Its flagship product XEOMIN® addresses dystonia and spasticity, while recent efforts include Phase 2 trials for peripheral neuropathic pain and expanded approvals for cervical dystonia and blepharospasm in Japan.

Merz Therapeutics

Verified Nov 2026

AT A GLANCE

Founded

2020

Headquarters

Germany flag

Frankfurt, Hesse

Employees

1,000-5,000

Ownership

Merz Therapeutics at a glance

Revenue

$250-500M

Est. band

Employees

1,000-5,000

Founded

2020

Headquarters

Frankfurt, Hesse

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Overview

Merz Therapeutics is a specialty pharmaceutical company headquartered in Frankfurt, Germany, founded in 2020, with 1,000–5,000 employees and estimated revenue of $250–500 million. Part of the Merz Group, which traces its heritage to 1908, the company develops treatments for neurological movement disorders, neurodegenerative diseases, and related conditions. Its flagship product XEOMIN® addresses dystonia and spasticity, while recent efforts include Phase 2 trials for peripheral neuropathic pain and expanded approvals for cervical dystonia and blepharospasm in Japan.

At a glance

Attribute

Detail

Founded

2020

Headquarters

Frankfurt, Hesse

Employees

1,000-5,000

Revenue

$250-500M (estimated)

What Merz Therapeutics makes

Merz Therapeutics manufactures and commercializes neurotoxin-based therapies, biopharmaceuticals for movement disorders, and treatments for neurodegenerative diseases including Alzheimer's and Parkinson's.

Latest developments

Facilities

Merz Therapeutics is headquartered in Frankfurt, Hesse. Public sources also reference these locations:

Company details

As a privately held subsidiary of the Merz Group, the company operates facilities in Poland and Frankfurt and serves multiple therapeutic areas including dermatology, hair loss, and scar management. Merz Therapeutics was founded in 2020, has an estimated 1,000-5,000 employees, and is headquartered in Frankfurt, Hesse.

Frequently asked questions

What does Merz Therapeutics do?

Merz Therapeutics is a specialty pharmaceutical company headquartered in Frankfurt, Germany, founded in 2020, with 1,000–5,000 employees and estimated revenue of $250–500 million. Part of the Merz Group, which traces its heritage to 1908, the company develops treatments for neurological movement disorders, neurodegenerative diseases, and related conditions. Its flagship product XEOMIN® addresses dystonia and spasticity, while recent efforts include Phase 2 trials for peripheral neuropathic pain and expanded approvals for cervical dystonia and blepharospasm in Japan.

Where is Merz Therapeutics headquartered?

Merz Therapeutics is headquartered in Frankfurt, Hesse.

When was Merz Therapeutics founded?

Merz Therapeutics was founded in 2020.

How big is Merz Therapeutics?

Merz Therapeutics has an estimated 1,000-5,000 employees, with revenue in the $250-500M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Frankfurt, Hesse (HQ)Headquarters · Hesse, Germany
Frankfurt, Hesse (HQ)Frankfurt, Hesse, GermanyHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.